PCVX

Vaxcyte, Inc.

CIK 0001649094 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)

$59.83

↑ 1.12 (1.91%)

as of Jul 9, 2026

End-of-day close, not real-time intraday

Live price (Google Finance) ↗

Overall read: NeutralOverall score · based on 4/4 lenses

FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals

Key stats

Market Cap

$8.64B

P/E Ratio

-9.13

EPS

-5.63

Dividend Yield

Not covered

52W Position

86%

Beta

0.93

Valuation multiples

Fwd P/E

Not covered

PEG

Not covered

P/B

2.88

P/S

Not covered

EV/Revenue

Not covered

ROE

-31.6%

Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 86%

$29.08$65.00

Latest Financials

2025-12-31 FY

Revenue

–

Net Income

-$766.63M

Total Assets

$3.00B

Free Cash Flow

-$669.29M

PCVX

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news

PCVX

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news